Iron infusion trial aims to boost exercise in lung disease patients
NCT ID NCT07359599
First seen Jan 23, 2026 · Last updated Jun 23, 2026 · Updated 17 times
Summary
This study tests whether giving iron through a vein can help people with pulmonary hypertension (high blood pressure in the lungs) who also have low iron levels. Many patients with this condition have trouble absorbing iron from pills. The trial will compare intravenous iron to a placebo in 306 participants, measuring how far they can walk in six minutes and their quality of life after 24 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AZ Groeninge
NOT_YET_RECRUITINGKortrijk, 8500, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
AZORG
NOT_YET_RECRUITINGAalst, 9300, Belgium
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Charleroi-Chimay
NOT_YET_RECRUITINGLodelinsart, 6042, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
CHU UCL Namur
NOT_YET_RECRUITINGYvoir, 5530, Belgium
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpital Erasme
NOT_YET_RECRUITINGBrussels, 1070, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
UZ Leuven
NOT_YET_RECRUITINGLeuven, 3000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Ziekenhuis Oost-Limburg
RECRUITINGGenk, 3600, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ferric carboxymaltose (intravenous iron)
What this could lead to
If it works, this could offer a new way to improve exercise capacity and quality of life for many pulmonary hypertension patients who also have iron deficiency.
What could go wrong
This is a phase 4 trial, but it's still uncertain whether correcting iron deficiency will actually improve symptoms. The study is relatively small and the effect may be modest or absent.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.